95252 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#2102Nuclear transport modulators and uses thereof
#2103Process for making beta 3 agonists and intermediates
#2104ARYL HYDROCARBON RECEPTOR (AHR) MODULATOR COMPOUNDS
#2105Solid forms of cerdulatinib
#2106Arylation method
#2107BENZAZEPINE COMPOUNDS, CONJUGATES, AND USES THEREOF
#2108Drugs and compositions for the treatment of ocular disorders
#2109Compounds and their use as PDE4 activators
#2110MEK INHIBITORS AND METHODS OF THEIR USE
#2111Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
#2112Inhibitors of cyclin-dependent kinases
#2113Substituted reverse pyrimidine Bmi-1 inhibitors
#2114Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
#2115Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#2116Hydantoin containing deoxyuridine triphosphatase inhibitors
#2117NOVEL 5-ACYLSULFANYL-HISTIDINE COMPOUNDS AS PRECURSORS OF THE CORRESPONDING 5-SULFANYLHISTIDINES AND THEIR DISULFIDES
#2118Compounds and their use for reducing uric acid levels
#2119Compounds and their use for reducing uric acid levels
#2120Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone
#2121Dimeric contrast agents
#2122Substituted quinazolines as matrix metalloproteinase-9 hemopexin domain inhibitors
#2123Cannabinoid receptor modulators
#2124TETRACYCLIC COMPOUND
#2125Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases
#2126Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase
#2127Substituted pyrimidines for treating bacterial infections
#2128Amino pyrimidine derivatives
#2129Pharmaceutically active compounds
#2130Urea derivative or pharmacologically acceptable salt thereof
#2131ALKYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS
#2132FUNGICIDAL PYRAZOLES
#2133Sulfoximine glycosidase inhibitors
#2134Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan
#2135SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
#2136Heterocyclic compounds useful as Pim kinase inhibitors
#2137Aminopyrazine derivatives as PI3K-γ inhibitors
#2138Inhibitors of EGFR and methods of use thereof
#2139Phthalazinone derivatives
#2140CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY
#2141Agent for removing undifferentiated iPS cells
#21422-arylsulfonamido-N-arylacetamide derivatized STAT3 inhibitors
#2143Process for the preparation of bazedoxifene
#2144Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
#2145Inhibition of OLIG2 activity
#2146Pyrimidines and variants thereof, and uses therefor
#2147Covalent inhibitors of KRas G12C
#2148Substituted dihydrobenzofuran glycosidase inhibitors
#21493-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
#2150Tetrazolinone compounds and its use as pest control agents
#2151Carboxamide compounds and uses thereof
#2152Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitors
#2153Radiotracer derivatives of trimethoprim for diagnostic imaging
#2154Methods of synthesizing thyroid hormone analogs and polymorphs thereof
#2155Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
#2156Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
#2157Pyrazole derivatives as bromodomain inhibitors
#2158Germination promoters
#2159MALEATE SALTS OF A QUINAZOLINE DERIVATIVE USEFUL AS AN ANTIANGIOGENIC AGENT
#2160Compounds for the treatment of HIV
#21613-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
#2162Hepatitis B capsid assembly modulators
#2163Modulators of the eIF2alpha pathway
#2164Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
#2165Glycosidase inhibitors
#2166HETEROCYCLIC COMPOUNDS AND USES THEREOF
#2167Quinazoline derivative
#2168Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
#2169Benzodiazepine derivatives and uses thereof
#2170Heteroaromatic compounds and their use as dopamine D1 ligands
#2171Heterocyclic compounds as pesticides
#2172Heterocyclic compounds as pesticides
#2173BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE
#2174MASP-2 inhibitors and methods of use
#2175Heteroaryl SYK inhibitors
#2176Compounds useful for treating gastrointestinal tract disorders
#2177PYRROLIDINYL UREA, PYRROLIDINYL THIOUREA AND PYRROLIDINYL GUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS
#2178Amide compounds and method for making and using
#21792-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
#2180TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME
#2181[4-(1,3,3-TRIMETHYL-2-OXO-3,4-DIHYDRO-1H-QUINOXALIN-7-YL)PHENOXY]ETHYLOXY COMPOUND OR SALT THEREOF
#2182Sulfonylureas and related compounds and use of same
#2183Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#21842,4-pyrimidinediamine compounds and their uses
#21851,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
#2186Anthracene derivative, light emitting element using the same, and light emitting device using the same
#2187Methyllactam ring compound and pharmaceutical use thereof
#2188INHIBITORS OF BRUTON'S TYROSINE KINASE
#2189CANNABINOID RECEPTOR MEDIATING COMPOUNDS
#2190Reagents and methods for analysis of proteins and metabolites targeted by covalent probes
#2191Heparanase inhibitors and use thereof
#2192Dimeric contrast agents
#2193Therapeutic compounds and compositions
#2194Nitric oxide donors
#2195Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#2196SnAg alloy plating solution
#2197Viral replication inhibitors
#2198Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same
#2199Synthesis of cerdulatinib
#2200Indolinones compounds and their use in the treatment of fibrotic diseases
#2201Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
#2202Benzopiperazine compositions as BET bromodomain inhibitors
#2203Compounds
#2204ANTIBACTERIAL COMPOUNDS
#2205Hydrazide containing nuclear transport modulators and uses thereof
#2206Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
#2207FUSED RING COMPOUND, HIGH POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC COMPONENT
#2208Plant growth regulator compounds
#2209Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
#2210Biotin derivatives
#2211ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#2212SMYD INHIBITORS
#2213Compound, and production method thereof, and methods of treatment using the compound
#2214Heterocyclic apelin receptor (APJ) agonists and uses thereof
#2215HIV replication inhibiting pyrimidines
#2216Agricultural chemicals
#2217Human plasma kallikrein inhibitors
#22181-cyano-pyrrolidine compounds as USP30 inhibitors
#2219Modulators of toll-like receptors
#2220GLUT4 Selective Inhibitors for Cancer Therapy
#2221Multi-substituted pyrimidine derivatives with excellent kinase inhibitory activities
#2222Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
#2223Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
#2224Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same
#2225Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same
#2226GSK-3 inhibitors
#2227Apelin receptor (APJ) agonists and uses thereof
#2228Inhibitors of tryptophan 2,3-dioxygenase
#2229Substituted Pyrrolidines and Methods of Use
#2230Aromatic amine derivatives, preparation methods therefor, and uses thereof
#2231Substituted pyrimidines containing acidic groups as TLR7 modulators
#2232HIV inhibitor compounds
#2233Heteroaryl amides as inhibitors of protein aggregation
#22342-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
#2235Process for purification of pyrazolpyridazines
#2236Rho kinase inhibitors
#2237Substituted Pyrazole Derivatives As Selective CDK12/13 Inhibitors
#2238Quinoxaline compounds as type III receptor tyrosine kinase inhibitors
#2239Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity
#2240Substituted quinazolines for inhibiting kinase activity
#2241Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition
#2242Dopamine Dreceptor antagonist compounds
#2243Small molecule modulators of pantothenate kinases
#2244Salt of quinazoline derivative, preparation method therefor and application thereof
#2245Chemical Compounds
#2246Method for sealing a void in a well using a smart gel sealant
#2247NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME
#22482-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use
#2249Substituted quinoxaline DNA-PK inhibitors
#2250Cycloalkyl substituted triazole compounds as agonists of the APJ receptor
#2251Alkyl substituted triazole compounds as agonists of the APJ Receptor
#2252Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
#2253NOVEL ULK1 INHIBITORS AND METHODS USING SAME
#2254Triazole phenyl compounds as agonists of the APJ receptor
#2255Substituted quinazoline compounds and methods of use thereof
#22561-cyano-pyrrolidine compounds as USP30 inhibitors
#2257Triazolone compounds as mPGES-1 inhibitors
#2258METHOD OF TREATING SOLID TUMORS
#2259Substituted indazole compounds as RORgammaT inhibitors and uses thereof
#2260N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
#2261Triazole furan compounds as agonists of the APJ receptor
#2262Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid
#2263Heteroaryl inhibitors of PDE4
#2264Bicyclic-fused heteroaryl or aryl compounds
#22651-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof
#22666-substituted quinazolinone inhibitors
#2267DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#22681-cyano-pyrrolidine compounds as USP30 inhibitors
#2269Phenylpyrrolidinone formyl peptide 2 receptor agonists
#2270Modulators of cystic fibrosis transmembrane conductance regulator
#2271Somatostatin receptor subtype 4 (SSTR4) agonists
#2272Substituted sulfonyl amides for controlling animal pests
#2273C-anilinoquinazoline compounds and their use in treating cancer
#2274Therapeutic compounds and methods of use thereof
#2275Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
#2276ACSS2 inhibitors and methods of use thereof
#22773-phenyl-pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto
#2278Method and apparatus for sorting heterogeneous material
#2279Heterocyclic amides as kinase inhibitors
#2280Pyridine and Pyrazine Derivative for the Treatment of CF
#2281Indazole compounds and uses thereof
#2282Azole amides and amines as alpha v integrin inhibitors
#2283Cardiac sarcomere inhibitors
#2284LLS compounds for treatment of cancer
#2285Indazole compounds and uses thereof
#2286Diphenylaminopyrimidine and triazine compound, and pharmaceutical composition and use thereof
#2287Compositions and methods for inhibition of the JAK pathway
#2288Kinase inhibitors for the treatment of disease
#2289DNA-PK inhibitors
#22902,4-pyrimidinediamine compounds and their uses
#2291ULK1 inhibitors and methods using same
#2292Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
#2293NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL AND METHODS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
#2294Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same
#2295Non-selective kinase inhibitors
#2296Indole carboxamide compounds
#2297Tricyclic sulfones as RORγ modulators
#2298Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same
#2299Pyrimidine compound as JAK kinase inhibitor
#2300SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
#2301THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#2302Elimination of hepatitis B virus with antiviral agents
#2303Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#2304Nitrogen-containing heteroaryl compounds and methods of use thereof
#2305Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents
#2306Indole derivatives as estrogen receptor degraders
#2307Compounds
#2308BIOCIDAL COATINGS AND METHODS FOR MAKING SAME
#2309Crystalline form of Olaparib
#2310Pyrrolidine derivatives as PPAR agonists
#2311INDAZOLYL- AND INDOLYL-BENZAMIDE DERIVATIVES
#2312Carbazole derivatives
#2313Antiviral compounds
#2314Biaryl inhibitors of Bruton'S tyrosine kinase
#2315Therapeutic compounds and uses thereof
#2316Small molecule regulators of steroid receptor coactivators and methods of use thereof
#2317TRPV4 antagonists
#2318Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof
#2319QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
#23202,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
#2321BIFUNCTIONAL ANTIFUNGAL AGENTS AND METHODS OF TREATING FUNGAL INFECTION
#2322Inhibitors of fibroblast growth factor receptor and use thereof
#2323Aminoacylindazole immunomodulators for treatment of autoimmune diseases
#23246-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME
#2325Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
#2326Compounds and uses thereof for the modulation of hemoglobin
#2327Heterocyclic amides as kinase inhibitors
#2328Benzenesulfonamide compounds and their use as therapeutic agents
#2329Quinazolinones as PARP14 inhibitors
#23306-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists
#2331PYRAZINE DERIVATIVES WITH EXTENDED CONJUGATION AND METHODS OF USING THE SAME IN OPTICAL APPLICATIONS
#2332Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
#2333Spiro three-membered ring, spiro five-membered ring peptide deformylase inhibitor and use thereof in antibacteria and anti-tumor
#2334Inhibitors of lysine specific demethylase-1
#2335Inhibitor of lysine specific demethylase-1
#2336TETRAZOLE-CONTAINING 1,2-CYCLOPROPANE-CARBOXAMIDES
#2337toxin inhibitors
#2338Amino quinazolines as kinase inhibitors
#2339Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
#2340Process for preparing pyrazoles
#2341Combination pharmaceutical agents as RSV inhibitors
#23421-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
#23432,4-disubstituted pyrimidines useful as kinase inhibitors
#2344Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#23451-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitors
#2346Inhibitors of fibroblast activation protein
#2347Triazoles for the treatment of demyelinating dieases
#2348Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#23493-pyridyloxyphenyldihydrouracil compound and use thereof
#2350Pharmacokinetically improved compounds
#2351Pyrazolylaminobenzimidazole derivatives as JAK inhibitors
#23522-pyrrolidine phenylhydrazides antibacterial agents
#2353FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#2354Biaryl amide compounds as kinase inhibitors
#2355Heterocyclic compound
#2356Benzazepine compounds, conjugates, and uses thereof
#2357Benzazepine compounds, conjugates, and uses thereof
#2358Small molecule activators of Parkin enzyme function
#2359Methods of forming carbene-functionalized composite materials
#2360Tubulin inhibitors
#2361METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#2362Pyrimidine derivative, method for preparing same and use thereof in medicine
#2363Urea derivative or pharmacologically acceptable salt thereof
#2364PENDANT AMINES AND DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#2365Nuclear transport modulators and uses thereof
#2366Modulators of calcium release-activated calcium channel
#2367PRO-DRUGS OF NSAIAS WITH VERY HIGH SKIN AND MEMBRANES PENETRATION RATES AND THEIR NEW MEDICINAL USES
#2368ULK1 inhibitors and methods using same
#2369ISOINDOLINE, AZAISOINDOLINE, DIHYDROINDENONE AND DIHYDROAZAINDENONE INHIBITORS OF MNK1 AND MNK2
#2370Tetrahydroindazoles and medical uses thereof
#2371ABHD6 and dual ABHD6/MGL inhibitors and their uses
#2372N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B
#2373Amino compounds for treatment of complement mediated disorders
#2374Halogenated quinazolin-THF-amines as PDE1 inhibitors
#2375Metallo-beta-lactamase inhibitors
#2376Bicyclic proline compounds
#2377Quinazolines as potassium ion channel inhibitors
#23789-MEMBERED FUSED RING DERIVATIVE
#2379MEK Inhibitors and Methods of Their Use
#2380Benzopyrazole compounds and analogues thereof
#2381Quinazoline and indole compounds to treat medical disorders
#2382CARM1 inhibitors and uses thereof
#2383Crystalline form of compound suppressing protein kinase activity, and application thereof
#2384Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
#2385Diaminopyrimidine benzenesulfone derivatives and uses thereof
#2386Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)
#2387Substituted pyrimidine-4-carboxylic acids having anticancer activity
#2388SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#2389Indoline derivatives and method for using and producing the same
#2390Immunomodulator compounds
#2391SMALL MOLECULE INHIBITORS OF NECROPTOSIS
#2392Quinazoline compounds
#2393MODULATORS OF CELLULAR ADHESION
#2394Fungicidal pyridazinones
#2395Compound for organic electronic element, organic electronic element using same, and electronic device thereof
#2396Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins
#2397INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#2398Pyrimidine compound as JAK kinase inhibitor
#2399Compounds for modulating aquaporins
#2400Pyridazinone-based broad spectrum anti-influenza inhibitors